Showing results (1101-1110 of 3,921) with videos related to

Sort By:
Pageof 393
European Journal of Gynaecological Oncology|June 28, 2006
Efficiency of three surgical procedures in eliminating high-risk human papillomavirus infection in women with precancerous cervical lesionsN Jancar, S Rakar, M Poljak, et al.
European Journal of Gynaecological Oncology|June 28, 2006
Effective chemoradiotherapy protocol with 5-fluorouracil for cervical squamous cell carcinoma in vitroT Tanaka, K Yukawa, N Umesaki
European Journal of Gynaecological Oncology|June 28, 2006
Endometriosis and possible malignant transformationM Gojnic, V Dugalic, V Jeremic, et al.
European Journal of Gynaecological Oncology|June 28, 2006
Double laparotomy wound recurrence of endometrial carcinomaG C Balbi, A Cardone, A Monteverde, et al.
European Journal of Gynaecological Oncology|June 28, 2006
Female adnexal tumor of probable wolffian origin: clinicopathological, immunohistochemical and cytofluorimetric analyses of a 22-year-old virgin. case reportG C Balbi, L Del Piano, D Labriola, et al.
European Journal of Gynaecological Oncology|April 29, 2005
Assessment of ER-alpha and ER-beta expression levels in malicious tumors of the uterine corpusA Popiela, W Baranowsk, G Popiela, et al.
European Journal of Gynaecological Oncology|April 29, 2005
Epidemiology of hydatidiform mole in Finland, 1975 to 2001M Loukovaara, E Pukkala, P Lehtovirta, et al.
European Journal of Gynaecological Oncology|April 29, 2005
Mondor's disease of the breast: is there any relation to breast cancer?C Markopoulos, E Kouskos, D Mantas, et al.
European Journal of Gynaecological Oncology|January 1, 1992
Pelvic lymph node metastases in cervical cancer: comparison of lymphography, inspection, radiography, and histologic examination of lymph nodesG Stellato, L Tikkala, P Mäkelä, et al.
European Journal of Gynaecological Oncology|December 16, 2004
Expression of the cell-cycle regulatory proteins (cyclins D1 and E) in endometrial carcinomas: correlations with hormone receptor status, proliferating indices, tumor suppressor gene products (p53, pRb), and clinicopathological parametersA Mitselou, E Ioachim, N Zagorianakou, et al.
Pageof 393